These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10693175)
1. Methylcobalamin decreases mRNA levels of androgen-induced growth factor in androgen-dependent Shionogi carcinoma 115 cells. Nishizawa Y; Yamamoto T; Tanigaki Y; Kasugai T; Mano M; Ishiguro S; Fushiki S; Poirier LA; Nishizawa Y Nutr Cancer; 1999; 35(2):195-201. PubMed ID: 10693175 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in an androgen-dependent mouse mammary carcinoma cell line by methylcobalamin. Nishizawa Y; Goto HG; Tanigaki Y; Fushiki S; Nishizawa Y Anticancer Res; 2001; 21(2A):1107-10. PubMed ID: 11396147 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system]. Koga M; Kouhara H; Sato B Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813 [TBL] [Abstract][Full Text] [Related]
5. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture. Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211 [TBL] [Abstract][Full Text] [Related]
6. Methylcobalamin inhibits fibroblast growth factor-8 stimulated proliferation and induces apoptosis in Shionogi carcinoma cells. Goto GH; Katayama H; Tanigaki Y; Fushiki S; Nishizawa Y; Nishizawa Y Int J Vitam Nutr Res; 2008 Jan; 78(1):21-6. PubMed ID: 18654950 [TBL] [Abstract][Full Text] [Related]
7. Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells. Sato B; Kouhara H; Koga M; Kasayama S; Saito H; Sumitani S; Hashimoto K; Kishimoto T; Tanaka A; Matsumoto K J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):91-8. PubMed ID: 8274446 [TBL] [Abstract][Full Text] [Related]
8. Effects of methylcobalamin on the proliferation of androgen-sensitive or estrogen-sensitive malignant cells in culture and in vivo. Nishizawa Y; Yamamoto T; Terada N; Fushiki S; Matsumoto K; Nishizawa Y Int J Vitam Nutr Res; 1997; 67(3):164-70. PubMed ID: 9202976 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture. Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270 [TBL] [Abstract][Full Text] [Related]
10. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells. Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616 [TBL] [Abstract][Full Text] [Related]
11. Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115. Kasayama S; Sumitani S; Tanaka A; Yamanishi H; Nakamura N; Matsumoto K; Sato B J Cell Physiol; 1991 Aug; 148(2):260-6. PubMed ID: 1715343 [TBL] [Abstract][Full Text] [Related]
12. An essential role of androgen-induced growth factor in glucocorticoid-dependent autocrine loop in Shionogi carcinoma 115 cells. Yamanishi H; Tanaka A; Miyamoto K; Takeda M; Nishizawa Y; Koga M; Miyata M; Matsumoto K J Steroid Biochem Mol Biol; 1995 Jan; 52(1):49-53. PubMed ID: 7857873 [TBL] [Abstract][Full Text] [Related]
13. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium. Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337 [TBL] [Abstract][Full Text] [Related]
14. Growth-stimulatory effect of androgen-induced autocrine growth factor(s) secreted from Shionogi carcinoma 115 cells on androgen-unresponsive cancer cells in a paracrine mechanism. Nonomura N; Nakamura N; Uchida N; Noguchi S; Sato B; Sonoda T; Matsumoto K Cancer Res; 1988 Sep; 48(17):4904-8. PubMed ID: 3409225 [TBL] [Abstract][Full Text] [Related]
15. Facilitation of autonomous phenotype acquisition in androgen-dependent Shionogi carcinoma 115 cells by transfection of androgen-induced growth factor expression vector. Miyashita Y; Koga M; Kouhara H; Tanaka A; Kishimoto T; Sato B Jpn J Cancer Res; 1994 Nov; 85(11):1117-23. PubMed ID: 7829396 [TBL] [Abstract][Full Text] [Related]
16. Transforming activity of a newly cloned androgen-induced growth factor. Kouhara H; Koga M; Kasayama S; Tanaka A; Kishimoto T; Sato B Oncogene; 1994 Feb; 9(2):455-62. PubMed ID: 8290257 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115. Seike H; Takeuchi M; Kitamura Y; Sato B; Yamaguchi K; Matsumoto K Anticancer Res; 1983; 3(1):35-9. PubMed ID: 6830149 [TBL] [Abstract][Full Text] [Related]
19. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence. Bruchovsky N; Rennie PS; Otal N; Vanson A; Giles M; Pontifex H Cancer Res; 1985 Feb; 45(2):682-9. PubMed ID: 3967243 [TBL] [Abstract][Full Text] [Related]
20. Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo. Tanaka A; Hasegawa Y; Hakamata Y; Kamiakito T; Kuriki K; Yoshida H; Fukayama M J Cell Physiol; 2001 Aug; 188(2):194-200. PubMed ID: 11424086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]